Balancing Ertapenem Therapy in Recalcitrant Hidradenitis Suppurativa With Antibiotic Stewardship

Hidradenitis suppurativa (HS) is an often-overlooked, painful inflammatory condition associated with substantial physical, psychological, and social impairments, profoundly affecting the quality of life for individuals with the condition. The progress of drug development for HS has been impeded, partly due to a limited understanding of the condition. Despite 2 HS treatments approved by the US Food and Drug Administration and various off-label options, a uniformly effective therapeutic solution for HS remains elusive.
Source: JAMA Dermatology - Category: Dermatology Source Type: research